0QF:FRA
Moderna Inc
171,98 €
arrow_upward
+1,87%(+3,16) 1D
1. lis, 19:38:31 GMT+2 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 0QF...
Otvori
168,24 €
Najviša
175,10 €
Najniža
163,04 €
Trž. kap.
75,54 mlr.
Prosj. kol.
4,02 tis.
Količina
1,32 tis.
52-tjed. najviša
183,40 €
52-tjed. najniža
19,26 €
Broj djelatnika
5 tis.
Otvori
168,24 €
Najviša
175,10 €
Najniža
163,04 €
Trž. kap.
75,54 mlr.
Prosj. kol.
4,02 tis.
Količina
1,32 tis.
52-tjed. najviša
183,40 €
52-tjed. najniža
19,26 €
Broj djelatnika
5 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Benzinga
·
prije 44 minute
Moderna Stock Is Trending: What's Going On?
Investor's Business Daily
·
prije 1 sat
After Moderna's 'Outsized Run,' It May Be Time For This Bearish Move
Barchart.com
·
prije 2 sata
Why Citi Is Sounding the Alarm on Moderna Stock
Yahoo Finance
·
prije 3 sata
Moderna Climbs 3% Despite Citigroup’s Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water
Profil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
Moderna Inc – informacije
Glavni izvršni direktorStéphane Bancel
Zaposlenici4,7 tis.
Osnovanoruj 2010
Sjedište-
Sektor-
Web-lokacijamodernatx.com